Oracle Health Sciences
has strengthened its analytics offerings with the release of
Oracle® Clinical Development Analytics 2.0
and
Oracle Life Sciences Data Hub 2.1.4
.
Oracle’s life sciences analytics solutions help organizations accelerate insight and increase research and development efficiency. Oracle Clinical Development Analytics 2.0 expands beyond the product’s original focus on clinical data management to provide rich content for clinical operations.
With more than 360 pre-built and pre-sourced metrics and associated attributes, Oracle Clinical Development Analytics 2.0 enables life sciences organizations to gain insight into trial and program performance and make more informed business decisions by helping them to:
For comprehensive insight across the clinical trial environment, Oracle Clinical Development Analytics 2.0 now sources data directly from Oracle’s Siebel Clinical Trial Management System, in addition to information from Oracle Clinical and Oracle Remote Data Capture.
Oracle Life Sciences Data Hub 2.1.4 is a validated and secure data repository that integrates clinical, non-clinical and safety data from multiple sources into a unified environment. This helps enable organizations to streamline business processes around trial data acquisition, analysis and reporting. Updates to the latest version help:
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.